Incidence, range, and clinical effect of hemoglobin changes within 24 hours after transradial coronary stenting

American Journal of Cardiology

Volumn 106, Issue 2, 2010, Pages 155-161

  Bertrand, Olivier F ^a   Larose, Éric ^a   Rodés Cabau, Josep ^a   Rinfret, Stéphane ^a   Déry, Jean Pierre ^a   Bagur, Rodrigo ^a   Gleeton, Onil ^a   Nguyen, Can M ^a   Proulx, Guy ^a   De Larochellière, Robert ^a   Poirier, Paul ^a   Costerousse, Olivier ^a   Roy, Louis ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; BOLUS INJECTION; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL APPROACH; TRANSRADIAL CORONARY STENTING;

ACUTE CORONARY SYNDROME; AGED; ANEMIA; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HEMOGLOBINS; HEMORRHAGE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RADIAL ARTERY; STENTS; TIME FACTORS;

EID: 77955667672     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.03.013     Document Type: Article

References (29)

1. S.S. Jolly, S. Amlani, M. Hamon, S. Yusuf, and S.R. Mehta Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials Am Heart J 157 2009 132 140
2. O.F. Bertrand, E. Larose, J. Rodes-Cabau, O. Gleeton, I. Taillon, L. Roy, P. Poirier, O. Costerousse, and R.D. Larochelliere Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy Am Heart J 157 2009 164 169
3. F. Feit, M.D. Voeltz, M.J. Attubato, A.M. Lincoff, D.P. Chew, J.A. Bittl, E.J. Topol, and S.V. Manoukian Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial Am J Cardiol 100 2007 1364 1369
4. S.V. Manoukian, F. Feit, R. Mehran, M.D. Voeltz, R. Ebrahimi, M. Hamon, G.D. Dangas, A.M. Lincoff, H.D. White, J.W. Moses, S.B. King III, E.M. Ohman, and G.W. Stone Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial J Am Coll Cardiol 49 2007 1362 1368
5. S.R. Steinhubl, A. Kastrati, and P.B. Berger Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs Am Heart J 154 2007 3 11
6. M. Hamon, L.H. Rasmussen, S.V. Manoukian, A. Cequier, M.A. Lincoff, H.J. Rupprecht, B.J. Gersh, T. Mann, M.E. Bertrand, R. Mehran, and G.W. Stone Choice of arterial access site and outcomes in patients with acute coronary syndromes managed with an early invasive strategy: the ACUITY trial EuroIntervention 5 2009 115 120
7. S.R. Mehta, C.B. Granger, J.W. Eikelboom, J.P. Bassand, L. Wallentin, D.P. Faxon, R.J. Peters, A. Budaj, R. Afzal, S. Chrolavicius, K.A. Fox, and S. Yusuf Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial J Am Coll Cardiol 50 2007 1742 1751
8. G.W. Stone, B.T. McLaurin, D.A. Cox, M.E. Bertrand, A.M. Lincoff, J.W. Moses, H.D. White, S.J. Pocock, J.H. Ware, F. Feit, A. Colombo, P.E. Aylward, A.R. Cequier, H. Darius, W. Desmet, R. Ebrahimi, M. Hamon, L.H. Rasmussen, H.J. Rupprecht, J. Hoekstra, R. Mehran, and E.M. Ohman Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216
9. G. Maluenda, G. Lemesle, S.D. Collins, I. Ben-Dor, A.I. Syed, R. Torguson, K. Kaneshige, Z. Xue, R. Pakala, W.O. Suddath, L.F. Satler, K.M. Kent, J. Lindsay, A.D. Pichard, and R. Waksman The clinical significance of hematocrit values before and after percutaneous coronary intervention Am Heart J 158 2009 1024 1030
10. A.B. Catakoglu, S. Aytekin, M. Sener, H. Kurtoglu, H. Celebi, I.C. Demiroglu, and V. Aytekin Impact of anemia on nonfatal coronary events after percutaneous coronary interventions Heart Vessels 22 2007 383 388
11. P.C. Lee, A.S. Kini, C. Ahsan, E. Fisher, and S.K. Sharma Anemia is an independent predictor of mortality after percutaneous coronary intervention J Am Coll Cardiol 44 2004 541 546
12. R.S. McKechnie, D. Smith, C. Montoye, E. Kline-Rogers, M.J. O'Donnell, A.C. DeFranco, W.L. Meengs, R. McNamara, J.G. McGinnity, K. Patel, D. Share, A. Riba, S. Khanal, and M. Moscucci Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention Circulation 110 2004 271 277
13. H. Reinecke, T. Trey, J. Wellmann, J. Heidrich, M. Fobker, T. Wichter, M. Walter, G. Breithardt, and R.M. Schaefer Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions Eur Heart J 24 2003 2142 2150
14. M.D. Voeltz, A.D. Patel, F. Feit, R. Fazel, A.M. Lincoff, and S.V. Manoukian Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention Am J Cardiol 99 2007 1513 1517
15. O.F. Bertrand, R. De Larochelliere, J. Rodes-Cabau, G. Proulx, O. Gleeton, C.M. Nguyen, J.P. Dery, G. Barbeau, B. Noel, E. Larose, P. Poirier, and L. Roy A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation Circulation 114 2006 2636 2643
16. O.F. Bertrand, J. Rodes-Cabau, E. Larose, G. Proulx, O. Gleeton, C.M. Nguyen, I. Nault, L. Roy, P. Poirier, O. Costerousse, and R. De Larochelliere Early and late outcomes in patients excluded from same-day home discharge after transradial stenting and maximal antiplatelet therapy Catheter Cardiovasc Interv 72 2008 619 625
17. L. Mangin, O.F. Bertrand, R. de la Rochelliere, G. Proulx, R. Lemay, G. Barbeau, O. Gleeton, J. Rodes-Cabau, C.M. Nguyen, and L. Roy The transulnar approach for coronary intervention: a safe alternative to transradial approach in selected patients J Invasive Cardiol 17 2005 77 79
18. C.P. Cannon, A. Battler, R.G. Brindis, J.L. Cox, S.G. Ellis, N.R. Every, J.T. Flaherty, R.A. Harrington, H.M. Krumholz, M.L. Simoons, F.J. Van De Werf, W.S. Weintraub, K.R. Mitchell, S.L. Morrisson, H.V. Anderson, D.S. Cannom, W.R. Chitwood, J.E. Cigarroa, R.L. Collins-Nakai, R.J. Gibbons, F.L. Grover, P.A. Heidenreich, B.K. Khandheria, S.B. Knoebel, H.L. Krumholz, D.J. Malenka, D.B. Mark, C.R. McKay, E.R. Passamani, M.J. Radford, R.N. Riner, J.B. Schwartz, R.E. Shaw, R.J. Shemin, D.B. Van Fossen, E.D. Verrier, M.W. Watkins, D.R. Phoubandith, and T. Furnelli American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes: a report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee) J Am Coll Cardiol 38 2001 2114 2130
19. A.M. Lincoff, J.A. Bittl, R.A. Harrington, F. Feit, N.S. Kleiman, J.D. Jackman, I.J. Sarembock, D.J. Cohen, D. Spriggs, R. Ebrahimi, G. Keren, J. Carr, E.A. Cohen, A. Betriu, W. Desmet, D.J. Kereiakes, W. Rutsch, R.G. Wilcox, P.J. de Feyter, A. Vahanian, and E.J. Topol Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial JAMA 289 2003 853 863
20. R. Bagur, O.F. Bertrand, J. Rodes-Cabau, E. Larose, S. Rinfret, C.M. Nguyen, B. Noel, R.D. Larochelliere, P. Poirier, O. Costerousse, and L. Roy Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting Catheter Cardiovasc Interv 74 2009 1010 1016
21. W. Jauch, P.B. Kurnik, S.J. Hanlon, J.E. Siegel, and W.H. Matthai Jr Expected hemoglobin decrease following percutaneous transluminal coronary angioplasty Am J Cardiol 80 1997 71 74
22. W.H. Haught, M. Sokol, R.A. Kerensky, and J.L. Mehta Decrease in hematocrit after coronary stent placement and dextran therapy Am J Cardiol 76 1995 314 315
23. S.J. Phillips, M. Spector, R.H. Zeff, J.R. Skinner, R.S. Toon, A. Grignon, and C. Kongtahworn Hematocrit changes after uncomplicated percutaneous transluminal coronary angioplasty Am J Cardiol 64 1989 940
24. E.S. Roccario, M.J. Schweiger, S.S. Whitfield, W. Stikley, T. Weil, A. Urbano, and M. Porway Hematocrit fluctuations after percutaneous transluminal coronary angioplasty Am J Cardiol 68 1991 977 978
25. J.H. Chesebro, G. Knatterud, R. Roberts, J. Borer, L.S. Cohen, J. Dalen, H.T. Dodge, C.K. Francis, D. Hillis, and P. Ludbrook Thrombolysis in Myocardial Infarction (TIMI) trial: phase, a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: clinical findings through hospital discharge Circulation 76 1987 142 154
26. G. Montalescot, H.D. White, R. Gallo, M. Cohen, P.G. Steg, P.E. Aylward, C. Bode, M. Chiariello, S.B. King III, R.A. Harrington, W.J. Desmet, C. Macaya, and S.R. Steinhubl Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention N Engl J Med 355 2006 1006 1017
27. M.S. Sabatine, D.A. Morrow, R.P. Giugliano, P.B. Burton, S.A. Murphy, C.H. McCabe, C.M. Gibson, and E. Braunwald Association of hemoglobin levels with clinical outcomes in acute coronary syndromes Circulation 111 2005 2042 2049
28. E. Cavusoglu, V. Chopra, A. Gupta, L.T. Clark, C. Eng, and J.D. Marmur Usefulness of anemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome Am J Cardiol 98 2006 580 584
29. H. Tizon-Marcos, O.F. Bertrand, J. Rodes-Cabau, E. Larose, V. Gaudreault, R. Bagur, O. Gleeton, J. Courtis, L. Roy, P. Poirier, O. Costerousse, and R. De Larochelliere Impact of female gender and transradial coronary stenting with maximal antiplatelet therapy on bleeding and ischemic outcomes Am Heart J 157 2009 740 745